Mid-America Apartment Communities vs Healthpeak Properties

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (77 vs 78)
Mid-America Apartment Communities logo

Mid-America Apartment Communities

LeaderReal Estate & Property Tech

Enterprise

Germantown TN Sunbelt multifamily REIT (NYSE: MAA) ~$2.2B FY2024 revenue; 100K+ apartments in 300+ communities, supply-cycle navigation, 30+ year dividend growth competing with Camden Property Trust and AvalonBay.

AI VisibilityBeta
Overall Score
B77
Category Rank
#40 of 238
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
75
Perplexity
72
Gemini
74

About

Mid-America Apartment Communities, Inc. (MAA) is a Germantown, Tennessee-based multifamily apartment REIT — publicly traded on the New York Stock Exchange (NYSE: MAA) as an S&P 500 Real Estate component — owning, developing, and managing apartment communities across Sunbelt and Southeast United States markets including Dallas-Fort Worth, Atlanta, Charlotte, Raleigh, Tampa, Orlando, Nashville, Phoenix, Denver, and Austin through approximately 2,500 employees. MAA owns approximately 300 multifamily communities with 100,000+ apartment homes, concentrated in the high-growth Sunbelt markets that experienced explosive population and employment migration during and after COVID-19 as remote and hybrid work enabled households to relocate from high-cost coastal metro areas (New York, Los Angeles, San Francisco, Washington DC) to lower-cost Sun Belt cities. In fiscal year 2024, MAA reported revenues of approximately $2.2 billion, with same-store revenue growth moderating to approximately 0.5-1% as elevated new apartment supply (100,000+ new Sunbelt apartments completed annually in Dallas, Austin, Atlanta, Nashville, and Charlotte from 2022-2024 construction pipeline) competed with MAA's existing portfolio for residents — creating the Sunbelt apartment supply headwind that affected MAA alongside all Sunbelt-focused apartment REITs. CEO Eric Bolton has led MAA through the supply cycle, maintaining 95%+ physical occupancy through rent concessions and lease renewal incentives rather than accepting vacancy, and positioning MAA for the post-supply-peak recovery (projected 2026-2027) when the 40% decline in new apartment construction starts from 2023-2024 reduces new completions in 2026 below population demand growth.

Full profile
Healthpeak Properties logo

Healthpeak Properties

LeaderReal Estate & Property Tech

Enterprise

Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.

AI VisibilityBeta
Overall Score
B78
Category Rank
#24 of 238
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
72
Perplexity
74
Gemini
74

About

Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.

Full profile

AI Visibility Head-to-Head

77
Overall Score
78
#40
Category Rank
#24
79
AI Consensus
81
stable
Trend
stable
75
ChatGPT
72
72
Perplexity
74
74
Gemini
74
81
Claude
80
74
Grok
74

Key Details

Category
Enterprise
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.